185 related articles for article (PubMed ID: 17639029)
1. Does linezolid inhibit its own metabolism? Population pharmacokinetics as a tool to explain the observed nonlinearity in both healthy volunteers and septic patients.
Plock N; Buerger C; Joukhadar C; Kljucar S; Kloft C
Drug Metab Dispos; 2007 Oct; 35(10):1816-23. PubMed ID: 17639029
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic evaluation of linezolid in patients with major thermal injuries.
Lovering AM; Le Floch R; Hovsepian L; Stephanazzi J; Bret P; Birraux G; Vinsonneau C
J Antimicrob Chemother; 2009 Mar; 63(3):553-9. PubMed ID: 19153078
[TBL] [Abstract][Full Text] [Related]
3. Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion.
Adembri C; Fallani S; Cassetta MI; Arrigucci S; Ottaviano A; Pecile P; Mazzei T; De Gaudio R; Novelli A
Int J Antimicrob Agents; 2008 Feb; 31(2):122-9. PubMed ID: 18055183
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections.
MacGowan AP
J Antimicrob Chemother; 2003 May; 51 Suppl 2():ii17-25. PubMed ID: 12730139
[TBL] [Abstract][Full Text] [Related]
5. Effect of severity of sepsis on tissue concentrations of linezolid.
Thallinger C; Buerger C; Plock N; Kljucar S; Wuenscher S; Sauermann R; Kloft C; Joukhadar C
J Antimicrob Chemother; 2008 Jan; 61(1):173-6. PubMed ID: 17999976
[TBL] [Abstract][Full Text] [Related]
6. Linezolid pharmacokinetics in pediatric patients: an overview.
Jungbluth GL; Welshman IR; Hopkins NK
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S153-7. PubMed ID: 14520140
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and tolerance of single- and multiple-dose oral or intravenous linezolid, an oxazolidinone antibiotic, in healthy volunteers.
Stalker DJ; Jungbluth GL; Hopkins NK; Batts DH
J Antimicrob Chemother; 2003 May; 51(5):1239-46. PubMed ID: 12668582
[TBL] [Abstract][Full Text] [Related]
8. The effect of food on plasma and tissue concentrations of linezolid after multiple doses.
Islinger F; Dehghanyar P; Sauermann R; Bürger C; Kloft C; Müller M; Joukhadar C
Int J Antimicrob Agents; 2006 Feb; 27(2):108-12. PubMed ID: 16388930
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of linezolid in human non-inflamed vitreous after systemic administration.
Horcajada JP; Atienza R; Sarasa M; Soy D; Adán A; Mensa J
J Antimicrob Chemother; 2009 Mar; 63(3):550-2. PubMed ID: 19109336
[TBL] [Abstract][Full Text] [Related]
10. Impact of ontogeny on linezolid disposition in neonates and infants.
Kearns GL; Jungbluth GL; Abdel-Rahman SM; Hopkins NK; Welshman IR; Grzebyk RP; Bruss JB; Van Den Anker JN;
Clin Pharmacol Ther; 2003 Nov; 74(5):413-22. PubMed ID: 14586382
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic studies of linezolid and teicoplanin in the critically ill.
Whitehouse T; Cepeda JA; Shulman R; Aarons L; Nalda-Molina R; Tobin C; MacGowan A; Shaw S; Kibbler C; Singer M; Wilson AP
J Antimicrob Chemother; 2005 Mar; 55(3):333-40. PubMed ID: 15705641
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis.
Buerger C; Plock N; Dehghanyar P; Joukhadar C; Kloft C
Antimicrob Agents Chemother; 2006 Jul; 50(7):2455-63. PubMed ID: 16801426
[TBL] [Abstract][Full Text] [Related]
13. Multiple-dose pharmacokinetics of linezolid during continuous venovenous haemofiltration.
Meyer B; Kornek GV; Nikfardjam M; Karth GD; Heinz G; Locker GJ; Jaeger W; Thalhammer F
J Antimicrob Chemother; 2005 Jul; 56(1):172-9. PubMed ID: 15905303
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of linezolid in septic patients with and without extended dialysis.
Swoboda S; Ober MC; Lichtenstern C; Saleh S; Schwenger V; Sonntag HG; Haefeli WE; Hempel G; Hoppe-Tichy T; Weigand MA
Eur J Clin Pharmacol; 2010 Mar; 66(3):291-8. PubMed ID: 20013257
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [(14)C]linezolid to healthy human subjects.
Slatter JG; Stalker DJ; Feenstra KL; Welshman IR; Bruss JB; Sams JP; Johnson MG; Sanders PE; Hauer MJ; Fagerness PE; Stryd RP; Peng GW; Shobe EM
Drug Metab Dispos; 2001 Aug; 29(8):1136-45. PubMed ID: 11454733
[TBL] [Abstract][Full Text] [Related]
16. Plasma and cerebrospinal fluid concentrations of linezolid in neurosurgical critically ill patients with proven or suspected central nervous system infections.
Luque S; Grau S; Alvarez-Lerma F; Ferrández O; Campillo N; Horcajada JP; Basas M; Lipman J; Roberts JA
Int J Antimicrob Agents; 2014 Nov; 44(5):409-15. PubMed ID: 25216547
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the pharmacokinetics of linezolid in an obese Japanese patient.
Tsuji Y; Hiraki Y; Matsumoto K; Mizoguchi A; Sadoh S; Kobayashi T; Sakamoto S; Morita K; Yukawa E; Kamimura H; Karube Y
Scand J Infect Dis; 2012 Aug; 44(8):626-9. PubMed ID: 22263918
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of linezolid in bone tissue investigated by in vivo microdialysis.
Stolle LB; Plock N; Joukhadar C; Arpi M; Emmertsen KJ; Buerger C; Riegels-Nielsen P; Kloft C
Scand J Infect Dis; 2008; 40(1):24-9. PubMed ID: 18097982
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics of linezolid are not affected by concomitant intake of the antioxidant vitamins C and E.
Gordi T; Tan LH; Hong C; Hopkins NJ; Francom SF; Slatter JG; Antal EJ
J Clin Pharmacol; 2003 Oct; 43(10):1161-7. PubMed ID: 14517199
[TBL] [Abstract][Full Text] [Related]
20. Does haemodialysis significantly affect serum linezolid concentrations in critically ill patients with renal failure? A pilot investigation.
Fiaccadori E; Maggiore U; Rotelli C; Giacosa R; Parenti E; Picetti E; Manini P; Andreoli R; Cabassi A
Nephrol Dial Transplant; 2006 May; 21(5):1402-6. PubMed ID: 16504979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]